News & Updates

$Cabozantinib a new SoC for previously treated RAI-refractory DTC?$

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021 by

In individuals with radio-iodine-refractory differentiated thyroid cancer (RAI-refractory DTC) who have progressed during/after prior VEGFR-targeted therapy, the VEGFR2/MET/AXL/RET inhibitor cabozantinib showed a significant progression-free survival (PFS) benefit, according to findings of the phase III COSMIC-311 trial presented at ASCO 2021.

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021

Vaccination, antiviral therapy help curb HCC incidence, mortality in Taiwan

30 Jun 2021

Universal hepatitis B vaccination and antiviral therapy against viral hepatitis have helped minimize hepatocellular carcinoma (HCC) incidence and mortality rates among Taiwan’s young and middle-aged populations, a recent study has found.

Vaccination, antiviral therapy help curb HCC incidence, mortality in Taiwan

30 Jun 2021

Dealing with negative online comments

28 Jun 2021 by

The increasing use of social media and online reviews has made it easier for patients to comment publicly—on Facebook and Google reviews, for instance—on the care they receive. Positive comments are heartening for any healthcare professional to read.

Dealing with negative online comments

28 Jun 2021

CAR-T therapy induces high, durable response in R/R B-cell ALL

27 Jun 2021 by

A single infusion of brexucabtagene autoleucel (previously KTE-X19) induced high and durable response in heavily pretreated adults with relapsed or refractory (R/R) B-precursor acute lymphoblastic leukaemia (B-ALL), with a manageable safety profile, according to the pivotal ZUMA-3 trial presented at ASCO 2021.

CAR-T therapy induces high, durable response in R/R B-cell ALL

27 Jun 2021

Long-term PPI use does not increase gastric cancer risk

27 Jun 2021

Use of proton pump inhibitors (PPIs) in the long term, as compared to histamine 2 receptor antagonists (H2RAs), does not lead to a higher risk of gastric cancer even in a high-risk region, results of a large study have shown.

Long-term PPI use does not increase gastric cancer risk

27 Jun 2021

Lymphoma patients on proton therapy mostly young with lower mediastinal involvement

26 Jun 2021

Proton therapy-treated patients with mediastinal lymphoma, in general, are young and have lower mediastinal involvement, reports a study.

Lymphoma patients on proton therapy mostly young with lower mediastinal involvement

26 Jun 2021

Patient-focused strategies needed to improve adherence to TKI for chronic myeloid leukaemia

25 Jun 2021

Studies examining the impact of strategies to improve treatment adherence to tyrosine kinase inhibitors (TKIs) for chronic myeloid leukaemia have relied on large data sets instead of prospective trials, according to the results of a systematic review. In addition, current studies lack patient-focused interventions.

Patient-focused strategies needed to improve adherence to TKI for chronic myeloid leukaemia

25 Jun 2021

Clinical uncertainty on recurrent glioblastoma management proves need for trial

25 Jun 2021

Clinical uncertainty and equipoise concerning the question of reoperation for patients with recurrent glioblastoma (GBM) is enough to support the need for a randomized controlled trial (RCT), suggests a recent study.

Clinical uncertainty on recurrent glioblastoma management proves need for trial

25 Jun 2021

Younger adults at greater risk of regional, distant rectal cancer

24 Jun 2021

More and more young patients are developing regional and distant rectal cancer, a US study has found. Although patient age significantly predicts survival, chemotherapy seems ineffective in younger patients with localized and regional disease.

Younger adults at greater risk of regional, distant rectal cancer

24 Jun 2021

Knowledge regarding hormone therapy poor among BRCA mutation carriers

24 Jun 2021

Breast cancer patients who are BRCA mutation carriers seem to be mostly uninformed about the benefits and risks of hormone therapy, which may lead to poor perceptions of it, a recent study has found.

Knowledge regarding hormone therapy poor among BRCA mutation carriers

24 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

Vaccination, antiviral therapy help curb HCC incidence, mortality in Taiwan

Vaccination, antiviral therapy help curb HCC incidence, mortality in Taiwan

Dealing with negative online comments

Dealing with negative online comments

CAR-T therapy induces high, durable response in R/R B-cell ALL

CAR-T therapy induces high, durable response in R/R B-cell ALL

Long-term PPI use does not increase gastric cancer risk

Long-term PPI use does not increase gastric cancer risk

Lymphoma patients on proton therapy mostly young with lower mediastinal involvement

Lymphoma patients on proton therapy mostly young with lower mediastinal involvement

Patient-focused strategies needed to improve adherence to TKI for chronic myeloid leukaemia

Patient-focused strategies needed to improve adherence to TKI for chronic myeloid leukaemia

Clinical uncertainty on recurrent glioblastoma management proves need for trial

Clinical uncertainty on recurrent glioblastoma management proves need for trial

Younger adults at greater risk of regional, distant rectal cancer

Younger adults at greater risk of regional, distant rectal cancer

Knowledge regarding hormone therapy poor among BRCA mutation carriers

Knowledge regarding hormone therapy poor among BRCA mutation carriers